Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques

Detalhes bibliográficos
Autor(a) principal: Sá, Helena Isabel Oliveira
Data de Publicação: 2022
Outros Autores: Michelin, Michele, Tavares, T., Silva, Bruna Andreia Nogueira Airosa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/1822/80276
Resumo: The worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed.
id RCAP_cc5ad83801f7132cc6bf680bf811ee24
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/80276
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniquesOxidoreductasesPharmaceuticalsEnzyme immobilizationBiodegradationWastewaterHybrid techniquesScience & TechnologyThe worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed.This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit, and by LABBELS – Associate Laboratory in Biotechnology, Bioengineering and Microelectromechnaical Systems, LA/P/0029/2020. Helena Sá thanks FCT for funding her PhD grant (UI/BD/151239/2021).info:eu-repo/semantics/publishedVersionMultidisciplinary Digital Publishing Institute (MDPI)Universidade do MinhoSá, Helena Isabel OliveiraMichelin, MicheleTavares, T.Silva, Bruna Andreia Nogueira Airosa2022-10-152022-10-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/80276engSá, Helena; Michelin, Michele; Tavares, Teresa; Silva, Bruna, Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques. Biomolecules, 12(10), 1489, 20222218-273X10.3390/biom12101489362916981489https://www.mdpi.com/journal/biomoleculesinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:41:10Zoai:repositorium.sdum.uminho.pt:1822/80276Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:38:05.519659Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
title Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
spellingShingle Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
Sá, Helena Isabel Oliveira
Oxidoreductases
Pharmaceuticals
Enzyme immobilization
Biodegradation
Wastewater
Hybrid techniques
Science & Technology
title_short Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
title_full Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
title_fullStr Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
title_full_unstemmed Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
title_sort Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
author Sá, Helena Isabel Oliveira
author_facet Sá, Helena Isabel Oliveira
Michelin, Michele
Tavares, T.
Silva, Bruna Andreia Nogueira Airosa
author_role author
author2 Michelin, Michele
Tavares, T.
Silva, Bruna Andreia Nogueira Airosa
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Sá, Helena Isabel Oliveira
Michelin, Michele
Tavares, T.
Silva, Bruna Andreia Nogueira Airosa
dc.subject.por.fl_str_mv Oxidoreductases
Pharmaceuticals
Enzyme immobilization
Biodegradation
Wastewater
Hybrid techniques
Science & Technology
topic Oxidoreductases
Pharmaceuticals
Enzyme immobilization
Biodegradation
Wastewater
Hybrid techniques
Science & Technology
description The worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed.
publishDate 2022
dc.date.none.fl_str_mv 2022-10-15
2022-10-15T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1822/80276
url https://hdl.handle.net/1822/80276
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Sá, Helena; Michelin, Michele; Tavares, Teresa; Silva, Bruna, Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques. Biomolecules, 12(10), 1489, 2022
2218-273X
10.3390/biom12101489
36291698
1489
https://www.mdpi.com/journal/biomolecules
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132917204516864